Skip to content

DFDV DFDV Debt Securities, Current

Debt Securities, Current at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$533.28M+200%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$337.78M+37.0%
Xencor logo
XencorXNCR
$370.21M-2.8%
Block logo
BlockXYZ
$462.61M+30.4%
Nike logo
NikeNKE
$1.4B-22.0%
3M logo
3MMMM
$420M-39.8%

Other financials

Income statement

See full
Revenue$2.7M+828%
Gross profit$2.6M+814%
Operating income-$55.2M-6,154%
Net income-$83.4M-10,619%
EPS (diluted)-$3.18-3,875%

Balance sheet

See full
Cash & equivalents$3.7M+104%
Total debt$127.8M+226,535%
Total equity$10.2M+258%
Total assets$229.7M+5,425%

Cash flow

See full
Operating cash flow-$9.8M-1,151%
CapEx$500.0-95.0%
Free cash flow-$10.9M-5,681%

Valuation

See full
Market cap$88.55M-66.5%
Enterprise value$212.64M-25.1%
P/S6.4×-68.6×

Profitability

See full
Gross margin97.5%-0.9pp
Operating margin-659.3%-919pp
Net margin-1,136.4%-1,303pp
FCF margin-116.2%+98.4pp

Returns & leverage

See full
Return on equity-2,398.4%-2,467pp
Debt / equity12.5×+12.5×
Current ratio1.4×-1.5×

Where this comes from

Reported directly by DFDV in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesCurrent.

The official record: DFDV’s 10-Q, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about DFDV's debt securities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DFDV's debt securities, current?
DFDV (DFDV) reported debt securities, current of $0 in Q1 2026.